News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
BROADWOOD PARTNERS, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 19.6% stake in STAAR Surgical Company |
| 10/06/2023 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Bought 32,523 shares
@ $37.9316, valued at
$1.2M
Bought 97,474 shares
@ $37.9219, valued at
$3.7M
Bought 75,299 shares
@ $37.6156, valued at
$2.8M
|
|
| 04/05/2023 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on Oncocyte Corp|
Txns:
| Bought 26,827,638 shares
@ $0.3017, valued at
$8.1M
|
|
| 12/29/2022 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Bought 51,985 shares
@ $47.9087, valued at
$2.5M
Bought 100,000 shares
@ $46.9761, valued at
$4.7M
Bought 39,090 shares
@ $47.9261, valued at
$1.9M
|
|
| 12/08/2022 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 11/10/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/12/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/28/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/13/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 04/15/2022 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on Oncocyte Corp|
Txns:
| Bought 6,003,752 shares
@ $1.3325, valued at
$8M
Granted 5,882 convertible preferred
@ $1.53, valued at
$9k
Granted convertible preferred
@ $1.53, valued at
$0
Granted 6,003,752 options to buy
@ $1.53, valued at
$9.2M
Granted options to buy
@ $1.53, valued at
$0 |
|
| 04/15/2022 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 20% stake in Oncocyte Corporation |
| 03/25/2022 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Bought 260,106 shares
@ $1.366, valued at
$355.3k
Bought 200,000 shares
@ $1.4217, valued at
$284.3k
Bought 470,000 shares
@ $1.4426, valued at
$678k
|
|
| 03/25/2022 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 20.7% stake in Lineage Cell Therapeutics, Inc. |
| 02/11/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 12/09/2021 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 10/01/2021 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 18.2% stake in STAAR Surgical Company |
| 10/01/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Disposed of 71,577 shares
@ $0 |
|
| 09/24/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on Oncocyte Corp|
Txns:
| Exercised (in-or-at-the-money) shares
@ $0
Disposed/sold 573,461 options to buy
@ $3.25, valued at
$1.9M
Disposed/sold options to buy
@ $3.25, valued at
$0
Granted 573,461 options to buy
@ $3.1525, valued at
$1.8M
Granted options to buy
@ $3.1525, valued at
$0
Exercised (in-or-at-the-money) 573,461 options to buy
@ $3.1525, valued at
$1.8M
Exercised (in-or-at-the-money) options to buy
@ $3.1525, valued at
$0 |
|
| 09/24/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/13/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/02/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Disposed of 655 shares
@ $0 |
|
| 06/28/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Sold 67,708 shares
@ $157.83, valued at
$10.7M
Sold 30,735 shares
@ $155.84, valued at
$4.8M
Sold 130,000 shares
@ $155.19, valued at
$20.2M
|
|
| 06/21/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Sold 30,543 shares
@ $148.79, valued at
$4.5M
Sold 63,896 shares
@ $150.31, valued at
$9.6M
Sold 13,236 shares
@ $152.59, valued at
$2M
|
|
| 06/15/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Sold 2,275 shares
@ $147.05, valued at
$334.5k
Sold 21,895 shares
@ $147.79, valued at
$3.2M
Sold 35,380 shares
@ $147.46, valued at
$5.2M
|
|
| 06/15/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/01/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Sold 47,571 shares
@ $143.42, valued at
$6.8M
Sold 217,693 shares
@ $147.43, valued at
$32.1M
Sold 1,014 shares
@ $146.36, valued at
$148.4k
|
|
| 05/14/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 04/26/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Sold 20,669 shares
@ $130.34, valued at
$2.7M
Sold 53,854 shares
@ $133.51, valued at
$7.2M
Sold 43,383 shares
@ $135.3, valued at
$5.9M
|
|
| 04/05/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Gifted 100,000 shares
@ $0 |
|
| 04/05/2021 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 20.3% stake in STAAR Surgical Company |
| 03/16/2021 |
SC 13D/A
| BROADWOOD PARTNERS, L.P. reports a 21.2% stake in Lineage Cell Therapeutics, Inc. |
| 02/12/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Sold 7,789 shares
@ $124.9, valued at
$972.8k
Sold 7,412 shares
@ $124.51, valued at
$922.9k
Sold 22,250 shares
@ $124.22, valued at
$2.8M
|
|
| 02/12/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/09/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Sold 47,700 shares
@ $116.09, valued at
$5.5M
Sold 144,838 shares
@ $122.28, valued at
$17.7M
Sold 65,081 shares
@ $124.09, valued at
$8.1M
|
|
|
|
|